To better understand how the mutation status of KRAS influences survival signaling in cancer cells, we utilized data obtained from gene expression profiling of mouse KRAS G12D-induced lung adenocarcinomas and control untransformed cells, which we previously reported [10]. This evidence concerns the gene KRAS and lung adenocarcinoma.